NYSE$CVSA
Covista Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Adtalem's Q2 2024 performance reflected accelerated enrollment and revenue growth, driven by strong profitability and high-quality academic outcomes.
Adtalem Global Education reported an 8.4% increase in revenue and a 6.2% increase in total student enrollment for the second quarter of fiscal year 2024. Diluted earnings per share were $0.98, and adjusted EPS was $1.23, representing a 5.1% year-over-year growth. The company also raised its fiscal year 2024 guidance for revenue and adjusted earnings per share.
- Revenue increased by 8.4% year-over-year to $393.2 million.
- Total student enrollment grew by 6.2% year-over-year to 81,772.
- Diluted earnings per share reached $0.98, while adjusted EPS was $1.23, a 5.1% increase year-over-year.
- The company completed its $300 million share repurchase program and authorized a new $300 million program.
Headline financials
Revenue & EPS history
Adtalem · Revenue · Quarterly
$393M
Revenue by segment
Adtalem · $369M total across 3 segments · Q1 2024
- Chamberlain$143M+5.3%38.7%
- Walden$142M+8.2%38.4%
- Medical and Veterinary$84.6M-4.1%22.9%
Forward guidance
Adtalem raised its fiscal year 2024 outlook, expecting revenue between $1,520 million and $1,560 million, and adjusted earnings per share between $4.55 and $4.75.
Tailwinds
- Revenue guidance raised to $1,520 million - $1,560 million (previously $1,470 million - $1,530 million).
- Adjusted EPS guidance raised to $4.55 - $4.75 (previously $4.25 - $4.45).
- Strong top- and bottom-line performance expected to continue.
- Company is well-positioned to impact the U.S. healthcare workforce.
- Focus on delivering practice-ready clinicians at scale.
Headwinds
- Uncertainty of special items that may be incurred in the future.
- Risk factors described in the company's most recent Annual Report on Form 10-K.
- Factors that could cause actual results to differ materially from forward-looking statements.
- No reconciliation of non-GAAP guidance measures to corresponding GAAP measures is available.
- The company assumes no obligation to publicly update or revise its forward-looking statements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-0.7%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+0.7%
Avg return
30 days after
43%
29 / 67 earnings
Positive
+22.8%
Q1 2013
Best reaction
-33.2%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +13.2% | +10.2% | +8.0% | |
| Q2 2026 | -7.8% | -14.2% | -15.5% | |
| Q1 2026 | -33.2% | -31.2% | -34.7% | |
| Q3 2025 | +16.4% | +11.9% | +10.7% | |
| Q2 2025 | +4.6% | +7.5% | -0.1% | |
| Q1 2025 | +12.0% | +8.7% | +23.8% | |
| Q4 2024 | -7.3% | -2.1% | -2.2% | |
| Q3 2024 | +18.9% | +24.8% | +27.5% | |
| Q2 2024 | -13.9% | -17.5% | -15.6% | |
| Q1 2024 | +12.5% | +16.6% | +29.4% | |
| Q4 2023 | -1.1% | -4.0% | -0.8% | |
| Q3 2023 | +4.5% | +2.0% | +2.4% | |
| Q2 2023 | +13.7% | +3.1% | +2.2% | |
| Q1 2023 | +2.4% | +6.9% | -2.1% | |
| Q4 2022 | -3.1% | -2.6% | -2.8% | |
| Q3 2022 | +6.4% | +10.9% | +17.5% | |
| Q2 2022 | -12.7% | -16.0% | -15.2% | |
| Q1 2022 | -12.9% | -6.0% | -16.6% | |
| Q4 2021 | +1.3% | +0.3% | +11.8% | |
| Q3 2021 | -6.9% | -8.3% | -1.3% | |
| Q2 2021 | +0.1% | +0.9% | -2.8% | |
| Q1 2021 | +3.7% | +11.0% | +16.6% | |
| Q4 2020 | -4.4% | -6.5% | -25.9% | |
| Q3 2020 | +3.7% | +9.8% | +11.5% | |
| Q2 2020 | +3.1% | -3.0% | -14.9% | |
| Q1 2020 | -19.2% | -16.8% | -7.8% | |
| Q4 2019 | -12.5% | -14.6% | -20.9% | |
| Q3 2019 | -7.6% | -9.0% | -11.4% | |
| Q2 2019 | -3.3% | -3.6% | -4.1% | |
| Q1 2019 | +4.3% | +10.7% | +14.0% | |
| Q4 2018 | -15.8% | -13.5% | -20.0% | |
| Q3 2018 | -5.7% | -3.0% | +1.4% | |
| Q2 2018 | +7.1% | +3.7% | +12.3% | |
| Q1 2018 | -2.7% | +1.1% | +9.7% | |
| Q4 2017 | +4.3% | +4.0% | +8.1% | |
| Q3 2017 | -0.8% | +5.0% | +0.5% | |
| Q2 2017 | -0.5% | -3.0% | +0.2% | |
| Q1 2017 | +1.8% | +1.5% | +31.5% | |
| Q4 2016 | +17.7% | +11.8% | +4.3% | |
| Q3 2016 | +17.3% | — | — | |
| Q2 2016 | -14.2% | — | — | |
| Q1 2016 | -2.3% | — | — | |
| Q4 2015 | -7.7% | — | — | |
| Q3 2015 | -15.9% | — | — | |
| Q2 2015 | -17.9% | — | — | |
| Q1 2015 | +0.8% | — | — | |
| Q4 2014 | -3.2% | — | — | |
| Q3 2014 | +13.0% | — | — | |
| Q2 2014 | -2.6% | — | — | |
| Q1 2014 | +6.2% | — | — | |
| Q4 2013 | -9.5% | — | — | |
| Q3 2013 | -17.6% | — | — | |
| Q2 2013 | +19.1% | — | — | |
| Q1 2013 | +22.8% | — | — | |
| Q4 2009 | -2.2% | — | — | |
| Q4 2012 | -2.3% | — | — | |
| Q3 2012 | -0.4% | — | — | |
| Q2 2012 | -8.5% | — | — | |
| Q1 2012 | -0.8% | — | — | |
| Q4 2011 | +4.7% | — | — | |
| Q3 2011 | -1.4% | — | — | |
| Q3 2010 | -1.4% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q4 2010 | -1.1% | — | — | |
| Q1 2010 | -1.1% | — | — | |
| Q1 2011 | -1.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro